Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.

Source:http://linkedlifedata.com/resource/pubmed/id/15361643

Download in:

View as

General Info

PMID
15361643